Boeing stock slips as cash burn and 737 MAX production issues weigh on sentiment

Boeing Co. (ISIN US0970231058) stock has been trading under pressure on the NYSE as investors digest weaker 2024 cash flow prospects, slower aircraft deliveries, and ongoing scrutiny of 737 MAX production quality. The companys latest quarterly update for Q1 2024 showed a free cash outflow of about $3.9 billion, compared with a $0.8 billion outflow in Q1 2023, highlighting how deeply current disruptions are affecting liquidity.

Free cash flow down $3.1 billion year on year

According to Boeing’s Q1 2024 results published on its investor relations site on 24 April 2024, the group reported revenue of approximately $16.6 billion for the quarter, slightly up from about $17.9 billion in Q1 2023, while remaining well below pre?pandemic levels. The headline figure for investors, however, was the free cash flow metric: Boeing disclosed a free cash outflow of around $3.9 billion in Q1 2024, versus an outflow of roughly $0.8 billion a year earlier, a deterioration of about $3.1 billion driven largely by lower delivery volumes and inventory build?up.

In the same Q1 2024 update, Boeing indicated that its Commercial Airplanes segment delivered 83 aircraft in the quarter compared with 130 in Q1 2023, a reduction of 47 units year on year. The company noted that 737 MAX output had been constrained by additional inspections and rework after the mid?air incident involving an Alaska Airlines 737 MAX 9 in early January 2024, which led regulators to focus more closely on production and quality processes.

Revenue of $16.6 billion and operating loss persist

Boeing reported that Q1 2024 total revenue of about $16.6 billion compared with around $17.9 billion in the prior?year quarter, implying a decline of roughly $1.3 billion. Despite the slight sequential stabilization versus late 2023, the company still posted a core operating loss for Q1 2024, with negative earnings from the Commercial Airplanes and Defense segments continuing to weigh on the bottom line. Management emphasized that near?term financial performance would remain challenged until aircraft deliveries normalize and rework on existing inventory is completed.

In its guidance comments around the Q1 2024 release, Boeing indicated that it no longer expects to achieve the previously discussed target of around $10 billion in annual free cash flow by 2025, citing the effects of reduced 737 MAX production rates and the timing of customer advance payments. Instead, the company pointed to a more gradual recovery path for cash generation, contingent on regulatory approvals and the pace at which production can be safely increased.

737 MAX deliveries and safety costs

Boeing disclosed that in full?year 2023 its Commercial Airplanes division delivered 528 aircraft, up from 480 in 2022, with 396 of those in 2023 being 737 models. In its commentary, the company highlighted that while deliveries improved year on year, the pace still lagged the internal objective of reaching a sustainable monthly production rate of 50 aircraft for the 737 family later in the decade. Following the January 2024 MAX 9 incident and subsequent inspections, management has guided to lower near?term monthly 737 output in the low?twenties range until quality improvements are fully embedded.

For investors tracking Boeing stock, the cost of safety and quality remediation has become a central variable. In its 2023 annual report, Boeing recognized around $2.8 billion in additional charges related to its Defense, Space & Security segment, including work on the KC?46A tanker and the VC?25B Air Force One replacement program, reflecting program overruns and contract penalties. While not directly linked to 737 MAX issues, these charges underscore how multiple legacy programs are absorbing capital and complicating the path back to sustained profitability.

Market capitalization and NYSE trading context

On the NYSE, Boeing stock has been trading at a level that implies a market capitalization in the range of roughly $110 billion in mid?2024, down from a peak above $200 billion before the first 737 MAX grounding in 2019. The share price has reflected a risk premium for operational and regulatory uncertainty as the company works through accumulated inventories and steps up engagement with the Federal Aviation Administration on oversight of production processes.

For comparison, Airbus, Boeings main commercial rival listed in Europe, has been trading at a higher market capitalization and price?to?earnings multiple, reflecting its comparatively smoother production ramp and stronger recent delivery performance. This valuation gap illustrates how much investors currently discount Boeing’s execution risk and underscores the importance of restoring stable 737 MAX and 787 Dreamliner production volumes in the coming quarters.

Commercial aircraft as Boeings core product line

Boeings core product line remains its family of commercial jetliners, particularly the 737 MAX, 787 Dreamliner, and 777 series. In 2023, the Commercial Airplanes segment generated around $33.9 billion of revenue, up from approximately $25.9 billion in 2022, supported by higher 737 and 787 deliveries as travel demand recovered. Management has pointed out that long?term demand fundamentals for air travel remain intact, with a projected need for more than 42,000 new airplanes globally over the next 20 years according to its internal market outlook.

Beyond passenger aircraft, Boeing also produces freighters and offers conversion programs for older passenger jets, seeking to capture the structural growth in air cargo over the long term. However, current investor focus remains on passenger narrow?bodies like the 737 MAX, where execution challenges have the most direct impact on quarterly revenue, margins, and ultimately on Boeing stock valuation.

Recent price level of Boeing stock

As of 22 July 2024, Boeing stock closed on the NYSE at around $185 per share, keeping the shares well below their 52?week high near $267 but above the 52?week low close to $159. This trading range reflects investors attempts to balance the potential for a multi?year recovery in free cash flow against the near?term drag from production caps, regulatory oversight, and elevated program costs.